Rooks, J. B., et al. “Epidemiology of Hepatocellular Adenoma. The Role of Oral Contraceptive Use”. JAMA 242, no. 7 (1979): 644–48.

Rosenberg, L. “The Risk of Liver Neoplasia in Relation to Combined Oral Contraceptive Use”. Contraception 43, no. 6 (1991): 643–52.

Ruotolo, R., et al. “Anti-Estrogenic Activity of a Human Resveratrol Metabolite”. Nutrition, Metabolism, and Cardiovascular Diseases 23, no. 11 (2013): 1086–92.

Schuurman, H. J., et al. “Chemicals Trophic for the Thymus: Risk for Immunodeficiency and Autoimmunity”. International Journal of Immunopharmacology 14, no. 3 (1992): 369–75.

Shortell, C. K., et al. “Hepatic Adenoma and Focal Nodular Hyperplasia”. Surgery, Gynecology, and Obstetrics 173, no. 5 (1991): 426–31.

Søe, K. L., et al. “Liver Pathology Associated with the Use of Anabolic-Androgenic Steroids”. Liver 12, no. 2 (1992): 73–79.

Steiner, J. L., et al. “Dose-Dependent Benefits of Quercetin on Tumorigenesis in the C3(1)/ SV40Tag Transgenic Mouse Model of Breast Cancer”. Cancer Biology and Therapy 15, no. 11 (2014): 1456–67.

Ursin, G., et al. “Urinary 2-Hydroxyestrone/16Alpha-Hydroxyestrone Ratio and Risk of Breast Cancer in Postmenopausal Women”. Journal of the National Cancer Institute 91, no. 12 (1999): 1067–72.

Wallwiener, C. W., et al. “Prevalence of Sexual Dysfunction and Impact of Contraception in Female German Medical Students”. Journal of Sexual Medicine 7, no. 6 (2010): 2139–48.

Wu, Z., et al. “Progesterone Inhibits L-Type Calcium Currents in Gall Bladder Smooth Muscle Cells”. Journal of Gastroenterology and Hepatology 25, no. 12 (2010): 1838–43.

Yang, C. Z., et al. “Most Plastic Products Release Estrogenic Chemicals: A Potential Health Problem Tat Can Be Solved”. Environmental Health Perspectives 119, no. 7 (2011): 989–96.

Zhang, L. Q., et al. “Potential Therapeutic Targets for the Primary Gallbladder Carcinoma: Estrogen Receptors”. Asian Pacific Journal of Cancer Prevention 14, no. 4 (2013): 2185–90.

6. Оздоровление кишечника

Adlercreutz, H., et al. “Studies on the Role of Intestinal Bacteria in Metabolism of Synthetic and Natural Steroid Hormones”. Journal of Steroid Biochemistry 20, no. 1 (1984): 217–29.

Ashraf, M., et al. “The Presence of Anti-Thyroid and Anti-Ovarian Auto-Antibodies in Familial Premature Ovarian Failure”. International Journal of Fertility and Sterility 1, no. 4 (2008): 171–74.

Bast, A., et al. “Celiac Disease and Reproductive Health”. Practical Gastroenterology 35, no. 10 (2009): 10–21.

Bernier, M. O., et al. “Combined Oral Contraceptive Use and the Risk of Systemic Lupus Erythematosus”. Arthritis and Rheumatology 61, no. 4 (2009): 476–81.

Blasi, F., et al. “The Effect of N-Acetylcysteine on Biofilms: Implications for the Treatment of Respiratory Tract Infections”. Respiratory Medicine 117 (2016): 190–97.

Bultman, S. J. “The Microbiome and Its Potential as a Cancer Preventive Intervention”. Seminars in Oncology 43, no. 1 (2016): 97–106.

Campana, R., et al. “Strain-Specific Probiotic Properties of Lactic Acid Bacteria and Their Interference with Human Intestinal Pathogens Invasion”. Gut Pathogens 9, no. 1 (2017): 12.

Cook, L. C., et al. “The Role of Estrogen Signaling in a Mouse Model of Inflammatory Bowel Disease: A Helicobacter Hepaticus Model”. PLoS One 9, no. 4 (2014): e94209.

Costenbader, K. H., et al. “Reproductive and Menopausal Factors and Risk of Systemic Lupus Erythematosus in Women”. Arthritis and Rheumatology 56, no. 4 (2007): 1251–62.

Crujeiras, A. B., et al. “Leptin Resistance in Obesity: An Epigenetic Landscape”. Life Sciences 140 (2015): 57–63.

Cummings, S. R., et al. “Prevention of Breast Cancer in Postmenopausal Women: Approaches to Estimating and Reducing Risk”. Journal of the National Cancer Institute 101, no. 6 (2009): 384–98.

Cutolo, M., et al. “Estrogens and Autoimmune Diseases”. Annals of the New York Academy of Sciences 1089 (2006): 538–47.

Dai, Z. L., et al. “L-Glutamine Regulates Amino Acid Utilization by Intestinal Bacteria”. Amino Acids 45, no. 3 (2013): 501–12.

De Kort, S., et al. “Leaky Gut and Diabetes Mellitus: What Is the Link?” Obesity Reviews 12, no. 6 (2011): 449–58.

Dinicola, S., et al. “N-Acetylcysteine as Powerful Molecule to Destroy Bacterial Biofilms. A Systematic Review”. European Review for Medical and Pharmacological Sciences 18, no. 19 (2014): 2942–48.

Divi, R. L., et al. “Anti-thyroid Isoflavones from Soybean: Isolation, Characterization, and Mechanisms of Action”. Biochemical Pharmacology 54, no. 10 (1997): 1087–96.

Engen, P. A., et al. “The Gastrointestinal Microbiome: Alcohol Effects on the Composition of Intestinal Microbiota”. Alcohol Research 37, no. 2 (2015): 223–36.

Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit. “Contraceptive Choices for Women with Inflammatory Bowel Disease”. Journal of Family Planning and Reproductive Health Care 29, no. 3 (2003): 127–35. http://srh.bmj.com /content/familyplanning/29/3/127.full.pdf.

Fasano, A. “Leaky Gut and Autoimmune Diseases”. Clinical Reviews in Allergy and Immunology 42, no. 1 (2012): 71–78.

Fasano, A. “Zonulin, Regulation of Tight Junctions, and Autoimmune Diseases”. Annals of the New York Academy of Sciences 1258 (2012): 25–33.

Fasano, A., et al. “Mechanisms of Disease: The Role of Intestinal Barrier Function in the Pathogenesis of Gastrointestinal Autoimmune Diseases”. Nature Clinical Practice. Gastroenterology and Hepatology 2, no. 9 (2005): 416–22.

Fénichel, P., et al. “Prevalence, Specificity, and Significance of Ovarian Antibodies During Spontaneous Premature Ovarian Failure”. Human Reproduction 12, no. 12 (1997): 2623–28.

Fresko, I., et al. “Anti-Saccharomyces Cerevisiae Antibodies (ASCA) in Behçet’s Syndrome”. Clinical and Experimental Rheumatology 23, suppl. 38 (2005): S67–70.

Frieri, M. “Neuroimmunology and Inflammation: Implications for Therapy of Allergic and Autoimmune Diseases”. Annals of Allergy, Asthma, and Immunology 90, no. 6, suppl. 3 (2003): S34–40.

Gameiro, C. M., et al. “Menopause and Aging: Changes in the Immune System – A Review”. Maturitas 67, no. 4 (2010): 316–20.

Gawron, L., et al. “Oral Contraceptive Use and Crohn’s Disease Complications”. Gastroenterology 151, no. 5 (2016): 1038–39.

https://www.gastrojournal.org/article/S0016-5085 (16)35072-7/fulltext?code=ygast-site.

Harmon, Q. E., et al. “Use of Estrogen-Containing Contraception Is Associated with Increased Concentrations of 25-Hydroxy Vitamin D”. Journal of Clinical Endocrinology and Metabolism 101, no. 9 (2016): 3370–77. https://academic.oup.com/jcem/article /101/9/3370/2806637.